Abstract

ABSTRACTThe posterior cingulate cortex (PCC) and corpus callosum (CC) are susceptible to trauma, but injury often evades detection. PCC Metabolic disruption may predict CC white matter tract injury and the secondary cascade responsible for progression. While the time frame for the secondary cascade remains unclear in humans, the first 24 h (hyper-acute phase) are crucial for life-saving interventions.Objectives: To test whether Magnetic Resonance Imaging (MRI) markers are detectable in the hyper-acute phase and progress after traumatic brain injury (TBI) and whether alterations in these parameters reflect injury severity.Methods: Spectroscopic and diffusion-weighted MRI data were collected in 18 patients with TBI (within 24 h and repeated 7–15 days following injury) and 18 healthy controls (scanned once).Results: Within 24 h of TBI N-acetylaspartate was reduced (F = 11.43, p = 0.002) and choline increased (F = 10.67, p = 0.003), the latter driven by moderate-severe injury (F = 5.54, p = 0.03). Alterations in fractional anisotropy (FA) and axial diffusivity (AD) progressed between the two time-points in the splenium of the CC (p = 0.029 and p = 0.013). Gradual reductions in FA correlated with progressive increases in choline (p = 0.029).Conclusions: Metabolic disruption and structural injury can be detected within hours of trauma. Metabolic and diffusion parameters allow identification of severity and provide evidence of injury progression.

Highlights

  • Traumatic brain injury (TBI) is a leading cause of mortality and morbidity worldwide

  • Beyond the consequence of the primary injury that occurs on impact, the secondary metabolic cascade is central to the progression of injury and diffuse axonal injury (DAI)

  • We set out to investigate, firstly, whether such metabolic disruption would be evident in the posterior cingulate cortex (PCC) within hours of trauma and reflects disruption in markers of axon coherence in the associated corpus callosum (CC) and cingulum bundle (CB)

Read more

Summary

Introduction

Traumatic brain injury (TBI) is a leading cause of mortality and morbidity worldwide. Gaps in our knowledge regarding the pathophysiology of the secondary injury cascade in the first few hours following trauma limit our ability to accurately classify patients and optimize treatment. Biochemical and metabolic markers that reflect the broad pathophysiological heterogeneity and injury progression following TBI could potentially guide clinical decisions regarding hospital admission, escalation of care and therapeutic interventions in the hyper-acute phase (

Objectives
Methods
Results
Conclusion
Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call